0001562180-21-003716.txt : 20210524
0001562180-21-003716.hdr.sgml : 20210524
20210524204553
ACCESSION NUMBER: 0001562180-21-003716
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210520
FILED AS OF DATE: 20210524
DATE AS OF CHANGE: 20210524
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dearen Danny L.
CENTRAL INDEX KEY: 0001756438
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38721
FILM NUMBER: 21957062
MAIL ADDRESS:
STREET 1: 26 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axonics, Inc.
CENTRAL INDEX KEY: 0001603756
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 454744083
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-396-6322
MAIL ADDRESS:
STREET 1: 26 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: Axonics Modulation Technologies, Inc.
DATE OF NAME CHANGE: 20140326
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2021-05-20
false
0001603756
Axonics, Inc.
AXNX
0001756438
Dearen Danny L.
26 TECHNOLOGY DRIVE
IRVINE
CA
92618
false
true
false
false
See Remarks
Common Stock
2021-05-20
4
M
false
28291.00
14.19
A
38291.00
D
Common Stock
2021-05-20
4
M
false
9701.00
1.32
A
47992.00
D
Common Stock
2021-05-20
4
M
false
5142.00
1.32
A
53134.00
D
Common Stock
2021-05-20
4
S
false
18516.00
54.4537
D
34618.00
D
Common Stock
2021-05-20
4
S
false
24618.00
55.0465
D
10000.00
D
Common Stock
2021-05-21
4
M
false
991.00
1.32
A
10991.00
D
Common Stock
2021-05-21
4
M
false
5875.00
1.63
A
16866.00
D
Common Stock
2021-05-21
4
S
false
6866.00
55.2234
D
10000.00
D
Stock Option (Right to Buy)
14.19
2021-05-20
4
M
false
28291.00
0.00
D
2029-01-30
Common Stock
28291.00
63273.00
D
Stock Option (Right to Buy)
1.32
2021-05-20
4
M
false
9701.00
0.00
D
2027-05-23
Common Stock
9701.00
1616.00
D
Stock Option (Right to Buy)
1.32
2021-05-20
4
M
false
5142.00
0.00
D
2027-07-05
Common Stock
5142.00
11925.00
D
Stock Option (Right to Buy)
1.32
2021-05-21
4
M
false
991.00
0.00
D
2027-07-05
Common Stock
991.00
10934.00
D
Stock Option (Right to Buy)
1.63
2021-05-21
4
M
false
5875.00
0.00
D
2028-03-30
Common Stock
5875.00
28921.00
D
The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
This transaction was executed in multiple trades at prices ranging from $53.83 to $54.825. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $54.855 to $55.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $55.00 to $55.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on January 30, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on January 30, 2023, provided the reporting person remains in continuous service on each vesting date.
The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on May 23, 2017, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of May 23, 2017, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on July 5, 2017, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of July 5, 2017, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on March 30, 2018, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of March 30, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
/s/ Danny L. Dearen
2021-05-24